raloxifene hydrochloride has been researched along with Pelvic Floor Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, B; Lee, JH; Polan, ML; Wen, Y | 1 |
1 other study(ies) available for raloxifene hydrochloride and Pelvic Floor Diseases
Article | Year |
---|---|
The effect of raloxifene, a SERM, on extracellular matrix protein expression of pelvic fibroblasts.
Topics: Aged; Blotting, Western; Cells, Cultured; Collagen Type I; Collagen Type III; Drug Evaluation, Preclinical; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix Proteins; Female; Fibroblasts; Humans; Matrix Metalloproteinases; Middle Aged; Pelvic Floor Disorders; Polymerase Chain Reaction; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tissue Inhibitor of Metalloproteinases | 2012 |